
1. Scand J Immunol. 2016 Sep;84(3):191-3. doi: 10.1111/sji.12456.

Therapeutic Vaccination against A Modified Minimal Survivin Epitope Induces
Functional CD4 T Cells That Recognize Survivin-Expressing Cells.

Nitschke NJ(1), Bjoern J(1)(2), Met O(1)(2), Svane IM(1)(2), Andersen MH(1)(3).

Author information: 
(1)Center for Cancer Immune Therapy (CCIT), Department of Hematology, Copenhagen 
University Hospital, Herlev, Denmark.
(2)Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
(3)Department of Immunology and Microbiology, University of Copenhagen,
Copenhagen, Denmark.

DOI: 10.1111/sji.12456 
PMID: 27354164  [Indexed for MEDLINE]

